SCHEDULE 13G

Company

ONCOLYTICS BIOTECH INC

Filed

October 3, 2002

Accession Number

0001021408-02-012230

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →